# HFrEF Polypill in Sri Lanka RCT

Study · id `cardio:ct-nct07569640` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07569640](<https://clinicaltrials.gov/study/NCT07569640>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07569640

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1672 participants.

## Technical summary

Registry record NCT07569640. Randomized; single masking; primary purpose treatment. Start 2026-08-17 (actual); primary completion 2029-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1672 participants (planned count; ClinicalTrials.gov record NCT07569640, source copy `cardio:ctgov-nct07569640-2026-10-22`, retrieved 2026-10-26)
- Started: 2026-08-17 (actual) (ClinicalTrials.gov record NCT07569640, source copy `cardio:ctgov-nct07569640-2026-10-22`, retrieved 2026-10-26)
- Primary completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07569640, source copy `cardio:ctgov-nct07569640-2026-10-22`, retrieved 2026-10-26)
- Completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07569640, source copy `cardio:ctgov-nct07569640-2026-10-22`, retrieved 2026-10-26)
- Countries: Sri Lanka (ClinicalTrials.gov record NCT07569640, source copy `cardio:ctgov-nct07569640-2026-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07569640-2026-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: HFrEF Polypill in Sri Lanka RCT
- Condition: Heart Failure With Reduced Ejection Fraction
- Intervention (Other): Usual Care
- Intervention (Drug): HFrEF Polypill
- Lead sponsor: Washington University School of Medicine
- Lead sponsor class: OTHER
- Collaborator: Centre for Chronic Disease Control, India
- Collaborator class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: RemediumOne (Pvt) Ltd.
- Collaborator class: INDUSTRY
- Collaborator: University of Kelaniya
- Collaborator class: OTHER
- Collaborator: The George Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Washington University School of Medicine (`cardio:org-washington-university-school-of-medicine`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: The George Institute for Global Health (`core:george-institute`)

## Provenance

Content hash: 57e6b0c4076326a20760536fd3c3933526abeb89cf8af145dbea17a62fc3cf6b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
